Table 1.

Distribution of patients and clinical parameters in the Swedish and Norwegian data sets

Numbers will not add up exactly because of partial information on certain individual cases.

^aProgesterone (PR) and estrogen (ER) receptors measured by ligand binding; (pos) ≥0.5 fg/μg protein.

^bERBB2 amplification scored by ROMA as segmented ratio >0.1 above baseline.